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Perioperative myocardial infarction: diagnostic clues and prevention
Larry Nicholsa




The diagnosis of perioperative myocardial infarction can be missed if the pain is masked by postoperative analgesia and 
the possibility is not considered. This report is the case of a patient with a missed diagnosis of perioperative myocardial 
infarction. Myocardial injury and infarction from noncardiac surgery is currently the subject of intense interest and research. 
This report illustrates the importance of the diagnosis and suggests clues that can be used to make the diagnosis. 
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CASE REPORT
This 57-year-old man had severe degenerative joint 
disease, morbid obesity, hypertension, hyperlipidemia, 
gastro-esophageal reflux disease, depression and 
bilateral carpal tunnel syndrome. The patient 
underwent right hip replacement 14 months prior, 
which he described as the most painful experience 
of his life. The hip replacement was complicated by 
a postoperative pectoral muscle rupture secondary 
to supporting his weight with a walker. He had a 
40 pack-year history of smoking (one pack a day 
for 40 years). He drank minimal alcohol but was a 
former heavy drinker. He denied use of recreational 
drugs. He was a truck driver on disability leave. 
He had a history of exposure to asbestos for three 
years. His mother had died of breast cancer at age 
42. His father had died at age 67 of a heart attack. 
The patient’s chronic medications were celecoxib, 
tramadol, sertraline, atorvastatin and omeprazole.
During pre-operative evaluation for right knee 
replacement, chest x-ray showed a 3.6 cm left lung 
mass in the lingula. Transbronchial biopsy showed 
moderately differentiated squamous cell carcinoma. 
He underwent a complete metastatic work-up 
including computed tomography (CT) scan of the 
chest and upper abdomen, which revealed normal 
mediastinal nodes, no adrenal masses and no liver 
masses, but a 2.5 cm lingular mass abutting the 
pericardium at the apex of the heart. Bone scan was 
negative for metastatic disease. Pulmonary function 
tests revealed a first-second forced expiratory volume 
(FEV1) of 3.42 L (90% of predicted), forced vital 
capacity (FVC) of 4.79 L (102% of predicted) and 
diffusing capacity of the lungs for carbon monoxide 
(DLCO) of 24.7 mL/min/mm Hg (75% of predicted). 
Liver function tests were within normal limits. 
Adenosine myocardial perfusion study showed some 
inferolateral and posterolateral wall thinning on initial 
images with some improvement around the periphery 
of the defect on the delayed images, particularly in 
the posterolateral wall. Gated views demonstrated 
some hypokinesis in the inferolateral wall but the left 
ventricular ejection fraction was preserved at 62%. 
Perioperative myocardial infarction: diagnostic clues and prevention
2-5 Autops Case Rep (São Paulo). 2018;8(3):e2018032
The radiologist interpreted these findings as consistent 
with inferolateral and posterolateral wall scarring with 
some peri-scar ischemia along the posterolateral wall, 
but a cardiologist subsequently interpreted them as 
false positive.
The pat ient was admitted for left  upper 
lobe lobectomy. On admission at 06:15 his white 
blood cel l  count was 21,700/mm3 (reference 
range [RR]: 4,500-11,000/mm3) with left shift, 
hemoglobin 12.8 g/dL (RR: 13.5-17.5 g/dL), platelets 
237,000/mm3 (RR: 150,000-400,000/mm3), glucose 
99 mg/dL (RR: 70-110 mg/dL), cholesterol 181 mg/dL 
(RR: <200 mg/dL), with normal renal function tests, 
electrolytes, bilirubin, liver enzymes, and albumin. 
At 07:30, the patient’s temperature was 37 degrees C, 
pulse 60/minute, blood pressure 132/73 mm Hg, 
respirations 20/minute, height 183 cm and weight 
136.1 kg (body mass index 40,6). During the surgery 
from 10:15 to 14:50, the patient’s pulse ranged from 
80/minute to 108/minute and his blood pressure 
ranged from a transient low of 95/54 mm Hg to a 
high of 194/98 mm Hg. Intraoperatively at 12:26, 
arterial blood showed: pH 7.30, PCO2 51 mm Hg, 
PO2 153 mm Hg, hemoglobin 13 g/dL, and glucose 
121 mg/dL. The estimated blood loss was 600 mL. 
Following the procedure, the patient was extubated 
without difficulty. He was placed on a cardiac monitor 
post-operatively which showed a normal sinus rhythm. 
At 15:00 the patient complained of incisional and 
left shoulder pain he rated 7/10, which responded to 
two tablets of combination oxycodone 2.5 mg and 
acetaminophen 325 mg, along with 5 mg of morphine. 
At 15:10 chest x-ray showed the left lung expanded, 
but poor aeration and an enlarged heart.
On postoperative day 1, at 00:45 the patient had 
left shoulder pain he rated 9/10, which responded 
to two tablets of combination oxycodone 2.5 mg 
and acetaminophen 325 mg. At 08:00, he had 
recurrent pain he described as chest soreness, which 
responded to 5 mg of morphine. The patient was 
hoarse. His temperature rose from 36.2 degrees C at 
08:00 to 37.5 degrees C at midnight. His pulse was 
86-110/minute, blood pressure 101-136/60-74 mm 
Hg and respirations 16-24/minute. His chest was clear. 
He had pulse oximeter readings of 96 to 99%. Cardiac 
monitoring showed borderline sinus tachycardia 
at a rate of 100/minute, with 1 mm ST-segment 
depression. The patient’s fluid balance was 5115 mL 
positive. At 11:20 chest x-ray showed clear lungs and 
unchanged cardiomegaly.
On postoperative day 2, the patient became 
dyspneic with walking (with the assistance of 2 people). 
His maximum temperature was 37.9 degrees C, pulse 
86-106/minute, blood pressure 110-160/50-80 mm Hg 
and respirations 18-22/minute. Cardiac monitoring 
showed sinus tachycardia at a rate of 109/minute, with 
T-wave inversion. His fluid balance was 225 mL negative. 
Chest x-ray showed no change. On postoperative day 3, 
the patient became dyspneic with minimal activity. 
He was very diaphoretic. His maximum temperature 
was 37.5 degrees C, pulse 88-100/minute, blood 
pressure 120-126/70-78 mm Hg and respirations 
18-20/minute. His fluid balance was 245 mL negative. 
His white blood cell count was 15,200/cu mm, 
hemoglobin 11.1 g/dL, platelets 263,000/cu mm 
and glucose 119 mg/dL. Left vocal cord paresis was 
diagnosed. The left upper lobe lobectomy specimen 
was signed out showing moderately differentiated 
squamous cell carcinoma, 3.2 × 2.9 × 2.6 cm, with 
extension of tumor up to but not through overlying 
pleura, bronchial and vascular margins of resection 
free of neoplasm, no angiolymphatic invasion and 
no metastases in 8 lymph nodes, TNM stage 1B, 
T2 N0 MX. Enoxaparin therapy was initiated for deep 
venous thrombosis prophylaxis, given the patient’s 
relative immobility.
On postoperative day 5, the patient’s voice was 
still hoarse, but improving. His temperature was 
37.7 degrees C, pulse 80/minute, blood pressure 
140/80 mm Hg, respirations 18/minute and fluid 
balance 550 mL negative. He was discharged to his 
home.
The following day, at home, the patient became 
short of breath and an ambulance was called. Upon 
arrival, paramedics found the patient conscious, alert, 
sitting on the toilet and hyperventilating. The patient’s 
wife was holding his head up. The patient was in 
obvious respiratory distress, close to respiratory failure. 
His skin was extremely pale, with cyanosis around the 
lips and fingernails. The patient was unable to speak 
more than one word at a time. He was using accessory 
muscles of respiration. His pulse was 88/minute and 
respiratory rate 30/minute. A pulse oximeter showed 
oxygen saturation of 88% on room air. The patient was 
immediately given supplemental oxygen at 15 L/minute 
via a non-rebreather. In the ambulance, the patient 
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was conscious and alert, stating that he could not 
breathe. On arrival at the emergency department, the 
patient was transferred to a bed and reported to the 
staff, but then almost immediately suffered a cardiac 
arrest. Resuscitation was attempted for approximately 
1 hour. The patient could not be resuscitated.
AUTOPSY FINDINGS
Postmortem examination revealed 420 ml of 
partially clotted blood in the pericardium, associated 
with a cardiac rupture in the posterior wall of the 
left ventricle. The posterior wall of the left ventricle 
showed a 6.5 × 6 × 1 cm transmural acute myocardial 
infarction with histological features of an infarction 
6 days prior (Figure 1).
There was severe coronary atherosclerosis with 
over 75% stenosis of all three major epicardial arteries 
and an occlusive thrombosis of the proximal right 
coronary artery, 1.9 cm from the ostium (Figure 2).
Autopsy also revealed a tiny microscopic old 
subendocardial myocardial infarction of the septum, 
passive congestion of the liver, mild steatohepatitis 
with severe mixed macrovesicular and microvesicular 
steatosis, and severe acute prostatitis.
DISCUSSION
The antemortem and postmortem evidence 
suggests that this patient most likely suffered 
a myocardial infarction during surgery. He had 
hypotens ion dur ing surgery ,  but  not  in  the 
postoperative period. He had ST-segment depression 
on postoperative day 1 and T-wave inversion on 
postoperative day 2. Neither cardiac biomarkers for 
infarction nor 12-lead electrocardiography were done 
because myocardial infarction was not suspected. 
The symptoms of the infarction were apparently 
masked by the expected symptoms following left 
upper lobectomy. The histopathologic features of 
the myocardial infarction at autopsy were typical of 
an infarct nearing the end of the first week, but they 
are not specific enough to date the infarction to the 
intraoperative period. They are specific enough to 
date the infarction to the perioperative period, and 
the period of surgery, during which blood clotting is 
activated, is the most likely time that the thrombosis 
Figure 1. The dead cardiac myocytes (all but lower 
right corner) show hypereosinophilia and loss of nuclei, 
associated with an infiltrate of degenerating neutrophils, 
many of which have lysed, releasing basophilic debris 
(nuclear dust).
Figure 2. The apparent gaps in this luminal thrombosis 
are due to artefactual tissue folding, particularly around 
two calcifications, one of which has been pushed out of 
the tissue section by the microtome blade.
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shown in Figure 2 developed. Ultimately, the infarction 
led to myocardial rupture and the patient’s demise.
Surgery inevitably releases activated clotting 
factors and platelets into the circulation, so ischemia or 
infarction of the heart, the brain or other organs at sites 
of critical atherosclerosis is an inevitable risk of surgery. 
In an international study of 15,065 patients aged 45 
years or older who underwent inpatient noncardiac 
surgery, among the 1200 (8%) who had a postoperative 
peak troponin level of 0.03 ng/mL or greater judged 
due to myocardial ischemia, only 41.8% would have 
fulfilled the universal definition of myocardial infarction, 
but 30-day mortality was 3.87 higher.1 In a follow-up 
study of 21,842 similar patients, using high-sensitivity 
troponin T (hsTnT) measurements, 3904 (17.9%) had 
myocardial injury due to ischemia, but 3633 of these 
patients (93.1%) experienced no ischemic symptom.2 
In an Indian study of 1075 patients undergoing 
noncardiac surgery, 188 (17.5%) had a peak 12- or 
24-hour postoperative troponin level of 0.03 ng/mL or 
greater judged to represent myocardial injury, and these 
patients had a 30-day mortality of 11.7%, compared to 
2.5% among the patients without myocardial injury.3 
Myocardial ischemia and infarction are an important 
complication of noncardiac surgery in older adults, 
and this complication can be fatal, but symptoms of 
myocardial ischemia are not often present to prompt 
the diagnosis.
Clues missed in this case include ST-segment 
and T-wave changes on the cardiac monitoring for 
arrhythmias. If one looks at the cardiac monitor only 
for arrhythmias, changes of myocardial ischemia or 
infarction can be overlooked.
“The eye sees only what the mind is prepared 
to comprehend,” as the French philosopher Henri 
Bergson has said. Of course, ischemia must involve a 
substantial amount of heart muscle to cause changes 
visible on electrocardiography, and smaller areas of 
myocardial ischemia could cause a fatal arrhythmia. 
Another clue that was not so much missed as dismissed 
by the cardiologist who “cleared” the patient for chest 
surgery was the cardiac scan interpreted as positive by 
the radiologist and then reinterpreted as negative by 
the cardiologist. The patient had many major risk factors 
for atherosclerotic coronary artery disease, including his 
history of hyperlipidemia, hypertension, severe obesity 
and smoking, and his family history of the disease.
Patients with heart rates of 96/minute or higher 
prior to the induction of anesthesia were significantly 
more likely to have myocardial injury and postoperative 
mortality in the Indian study.3 Another parameter 
independent of electrocardiographic changes and 
symptoms of ischemia recently shown to predict 
perioperative myocardial injury is a widened pulse 
pressure. The results of one study suggested that a pulse 
pressure over 62 mm Hg could be a useful clinical sign 
of risk that could guide strategies to decrease the risk.4
Prevention has been the focus of recent studies. 
Inhibiting platelets was prospectively studied for 
the purpose of preventing myocardial injury during 
noncardiac surgery and the administration of aspirin 
before surgery and in the early postsurgical period was 
found to have no significant effect on the rate of a 
composite of death or nonfatal myocardial infarction, 
but to be associated with an increased the risk of major 
bleeding.5 Studies of other preventative measures have 
had promising preliminary results, but large scale trial 
results are pending.6,7 In the meantime, this report 
can help raise awareness of intraoperative myocardial 
injury, illustrate the importance of the diagnosis and 
suggest clues that can be used to make the diagnosis.
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